The U.S. FDA is cracking down on lax testing practices by dozens of makers of healthcare products following hundreds of deaths overseas from contaminated
The U.S. FDA is cracking down on lax testing practices by dozens of makers of healthcare products following hundreds of deaths overseas from contaminated
The Food and Drug Administration has reprimanded at least 28 companies this year, saying they failed to prove sufficient testing of ingredients used in over-the-counter drugs and consumer products for the toxins ethylene glycol (EG) and diethylene glycol (DEG), according to a Reuters analysis of agency import alerts and warning letters to manufacturers. The manufacturers include U.S.-based companies and exporters from India, South Korea, Switzerland, Canada and Egypt.
The U.S. FDA is cracking down on lax testing practices by dozens of makers of health-care products following hundreds of deaths overseas from contaminated cough syrups, a Reuters review of regulatory alerts found.
My artwork is unapologetic, Taravat Talepasand said. Sometimes it can be very political. Sometimes it can be very controversial. The exhibition is at Macalester College in Minnesota